CRP and rheumatoid arthritis: In RA TNFα signalling promotes increased ROS production (66) and treatment with TNF blocking agents has shown amelioration of synovial oxygen tension and reduction in mtDNA mutation as well as improvement of disease activity calculated as DAS28 CRP (69).